Go Pro
OTCMKTS:HLTRF

HLS Therapeutics (HLTRF) Stock Price, News & Analysis

HLS Therapeutics logo
$2.75 -0.23 (-7.72%)
As of 08/11/2026 02:34 PM Eastern

About HLS Therapeutics Stock (OTCMKTS:HLTRF)

Advanced

Key Stats

Today's Range
$2.75
$2.90
50-Day Range
$2.75
$3.16
52-Week Range
$2.75
$4.02
Volume
200 shs
Average Volume
876 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

HLS Therapeutics is a specialty pharmaceutical company focused on the development, acquisition and commercialization of prescription products for niche therapeutic markets. Headquartered in Mississauga, Ontario, the company builds its portfolio through strategic licensing agreements and in-house development, with an emphasis on therapies that address unmet needs in neurology and rare disorders.

The company’s marketed offering includes treatments for neurological conditions, most notably primary periodic paralysis, for which it commercializes dichlorphenamide (Keveyis) in North America. HLS Therapeutics pursues a targeted approach, selecting products with established clinical profiles and clear regulatory pathways, and supports each launch with dedicated field teams and medical affairs activities.

HLS Therapeutics serves both the Canadian and U.S. markets, leveraging partnerships to extend its reach and optimize supply chains. The company’s leadership team comprises industry veterans with experience in specialty pharmaceuticals, regulatory affairs and commercial operations, guiding its efforts to expand its portfolio through disciplined business development and product lifecycle management.

AI Generated. May Contain Errors.

Receive HLTRF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HLS Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HLTRF Stock News Headlines

HLS Therapeutics Inc HLTRF
The oil crisis is spreading faster than you think
Tanker traffic through Hormuz has plunged from 110-130 daily transits to near zero, while 17% of Qatar's LNG capacity remains offline after missile strikes. Goldman Sachs named the UK the developed economy most exposed to a jet-fuel crunch, citing critically low reserves and a gutted refining base. Dow Chemical has already doubled polyethylene prices overnight. Garrett Goggin, CFA, CMT, points to four gold miners positioned for what comes next.tc pixel
HLS Therapeutics Announces Fiscal 2025 Financial Results
See More Headlines

HLTRF Stock Analysis - Frequently Asked Questions

HLS Therapeutics' stock was trading at $3.43 at the beginning of 2026. Since then, HLTRF stock has decreased by 19.8% and is now trading at $2.75.

Shares of HLTRF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:HLTRF
CIK
N/A
Fax
N/A
Employees
91
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

This page (OTCMKTS:HLTRF) was last updated on 8/12/2026 by MarketBeat.com Staff.
From Our Partners